Yes, patients with a history of stroke can and should use nicotine gum if they smoke, as part of a comprehensive smoking cessation strategy.
Nicotine replacement therapy, including nicotine gum, is explicitly recommended by the American Heart Association/American Stroke Association for stroke survivors who smoke, with counseling and pharmacotherapy receiving a Class 1, Level A recommendation 1.
Why This Recommendation Makes Sense
The evidence strongly supports that continuing to smoke after a stroke approximately doubles the risk of recurrent stroke and increases mortality 1. The benefit of quitting smoking far outweighs any theoretical concerns about nicotine replacement therapy in this population.
Key Evidence Supporting Nicotine Gum Use:
Guideline-based recommendation: The 2021 AHA/ASA stroke prevention guidelines give the highest level recommendation (Class 1, Level A) for nicotine replacement therapy combined with counseling in stroke/TIA patients who smoke 1
Safety profile: While research specifically in stroke populations is limited, available data show that nicotine replacement therapy combined with behavioral interventions achieves cessation rates of 33-66% versus 15-46% without pharmacotherapy 2
FDA-approved: Nicotine gum is an FDA-approved smoking cessation aid available over-the-counter 3
How to Prescribe Nicotine Gum Properly
Dosing strategy (based on Canadian Cardiovascular Society 2025 guidelines) 4:
For patients smoking <10 cigarettes/day: Nicotine gum can be used as monotherapy
- Use 2 mg strength
- Each piece delivers approximately 1 mg systemically (only half is absorbed)
For patients smoking ≥10 cigarettes/day: Combine nicotine gum with long-acting nicotine patches
- Use 4 mg strength gum
- Gum serves as "rescue" therapy for breakthrough cravings
- Can use up to 20 pieces per day
Critical counseling point - The "chew and park" method 4:
- Chew 2-3 times until peppery taste appears
- Park between gum and cheek for 15-30 minutes
- Do NOT continuously chew (causes GI symptoms and poor absorption)
Duration: Use for full 12 weeks minimum, with some evidence supporting longer treatment periods 4
Important Caveats
One Exception - Subarachnoid Hemorrhage (SAH):
Exercise caution in patients with subarachnoid hemorrhage specifically. One study found increased seizures (9% vs 2%) and delirium (19% vs 7%) with NRT in SAH patients 2. However, this does NOT apply to ischemic stroke or TIA patients, who comprise the vast majority of stroke cases.
What About Light Smokers?
Recent data suggest that light smokers (≤10 cigarettes/day) may have worse outcomes with NRT in the SAH population specifically, with higher rates of poor outcome (29% vs 12%) 5. However, this finding is limited to SAH patients and should not prevent NRT use in ischemic stroke patients.
The Bottom Line Algorithm
For ischemic stroke or TIA patients who smoke:
- ✓ Recommend nicotine gum + counseling (Class 1 recommendation)
- ✓ Combine with long-acting patch if smoking ≥10 cigarettes/day
- ✓ Teach proper "chew and park" technique
- ✓ Use for minimum 12 weeks
For subarachnoid hemorrhage patients:
- Consider alternative cessation strategies first
- If using NRT, monitor closely for seizures and delirium
- May avoid in light smokers (<10 cigarettes/day)
The mortality and morbidity reduction from smoking cessation after stroke is substantial and well-documented, making nicotine replacement therapy a critical intervention despite the nicotine content 1.